GlassScriptPhysician profile
Timothy T Robinson
NPI 1689754582
$1,899.81
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,224 · 2020: $404 · 2021: $255 · 2024: $15.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $405.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $254.08 | 2019-2021 | |
| Pfizer INC. | $167.39 | 2019-2020 | |
| Novo Nordisk INC | $150.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $130.54 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $127.11 | 2019-2021 | |
| Insmed, INC. | $121.34 | 2021 | |
| Amarin Pharma, INC. | $84.11 | 2019-2020 | |
| Astellas Pharma US INC | $79.31 | 2019-2020 | |
| Glaxosmithkline, LLC. | $59.25 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.29 | 2019-2020 | |
| Lilly USA, LLC | $42.65 | 2019 | |
| Genentech USA, INC. | $41.02 | 2019 | |
| Redhill Biopharma INC. | $40.69 | 2020-2021 | |
| Amgen INC. | $35.53 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $23.51 | 2019 | |
| Allergan, INC. | $19.61 | 2020 | |
| Mannkind Corporation | $18.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.35 | 2019 | |
| Daiichi Sankyo INC. | $15.69 | 2020 | |
| Acadia Pharmaceuticals INC | $15.65 | 2024 | Nuplazid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.